Status | Study |
Recruiting |
Study Name: Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors Condition: Glioma Pilocytic Astrocytoma Date: 2015-02-13 Interventions: Device: MRI-guided laser ablation |
Recruiting |
Study Name: Phase II Pegylated Interferon Condition: Juvenile Pilocytic Astrocytomas Optic Pathway Gliomas Date: 2015-01-08 Interventions: Drug: Pegylated interferon alpha-2b PEG-Intron 1mcg/kg/dose weekly through an injection under the skin o |
Withdrawn |
Study Name: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors Condition: Acoustic Schwannoma Adult Anaplastic Astrocytoma Adult Ana Date: 2014-07-16 Interventions: Radiation: gallium Ga 68-edotreotide |
Recruiting |
Study Name: Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas Condition: Adult Anaplastic Astrocytoma Adult Anaplastic Ependymoma A Date: 2014-07-07 Interventions: Radiation: Hyperfractionated radiation therapy |
Terminated |
Study Name: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas Condition: Adult Anaplastic Ependymoma Adult Anaplastic Oligodendroglioma Date: 2014-06-24 Interventions: Drug: 18F-fluoro-dihydroxyphenylalanine |
Recruiting |
Study Name: Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas Condition: Brain Tumor, Recurrent Date: 2013-10-17 Interventions: Drug: Photofrin photodynamic therapy. The subjects will re |
Recruiting |
Study Name: A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Condition: Pilomyxoid Astrocytoma Pilocytic Astrocytoma Date: 2013-04-16 Interventions: Drug: Mebendazole Mebendazole |
Recruiting |
Study Name: Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors Condition: Brain Tumor, Recurrent Date: 2012-09-05 Interventions: Drug: Photofrin (porfimer sodium) & photodynamic therapy. |
Active, not recruiting |
Study Name: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma Condition: Neurofibromatosis Type 1 Recurrent Childhood Pilocytic Astrocytoma Date: 2012-03-10 Interventions: Drug: Lenalidomide Given PO |
Active, not recruiting |
Study Name: Bevacizumab in Recurrent Grade II and III Glioma Condition: Central Nervous System Tumors Date: 2010-07-15 Interventions: Biological: Bevacizumab Bevaci |